Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures
The current outbreak of a novel coronavirus, named as SARS-CoV-2 causing COVID-19
occurred in 2019, is in dire need of finding potential therapeutic agents. Recently, ongoing …
occurred in 2019, is in dire need of finding potential therapeutic agents. Recently, ongoing …
[PDF][PDF] The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2
RR Narkhede, RS Cheke, JP Ambhore… - Eurasian J. Med …, 2020 - academia.edu
Objectives: The novel human coronavirus designated severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …
coronavirus 2 (SARS-CoV-2) first emerged in late 2019 in Wuhan, China. This virus spread …
Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2
K Kodchakorn, Y Poovorawan, K Suwannakarn… - Journal of Molecular …, 2020 - Elsevier
The widespread problem of a 2019-novel coronavirus (SARS-CoV-2) strain outbreak in
Wuhan, China has prompted a search for new drugs to protect against and treat this …
Wuhan, China has prompted a search for new drugs to protect against and treat this …
Molecular docking and dynamic simulations of some medicinal plants compounds against SARS-CoV-2: an in silico study
IA Adejoro, DD Babatunde… - Journal of Taibah …, 2020 - Taylor & Francis
ABSTRACT COVID-19 pandemic has poses urgent health challenge, and this project aims
to identify potential inhibitors to combat this virus. We screened 198 bioactive compounds …
to identify potential inhibitors to combat this virus. We screened 198 bioactive compounds …
In-silico screening and molecular dynamics simulation of drug bank experimental compounds against SARS-CoV-2
For the last few years, the world has been going through a difficult time, and the reason
behind this is severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), one of the …
behind this is severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), one of the …
In silico inquest reveals the efficacy of Cannabis in the treatment of post-Covid-19 related neurodegeneration
I Sarkar, G Sen, M Bhattacharya… - Journal of …, 2022 - Taylor & Francis
Abstract Coronavirus (SARS-CoV-2), the causative agent of the Covid-19 pandemic has
proved itself as the deadliest pathogen. A major portion of the population has become …
proved itself as the deadliest pathogen. A major portion of the population has become …
Proposing a fungal metabolite-flaviolin as a potential inhibitor of 3CLpro of novel coronavirus SARS-CoV-2 identified using docking and molecular dynamics
The novel SARS-CoV-2 is the etiological agent causing the Coronavirus disease 2019
(COVID-19), which continues to become an inevitable pandemic outbreak. Over a short …
(COVID-19), which continues to become an inevitable pandemic outbreak. Over a short …
Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach
S Mahanta, P Chowdhury, N Gogoi… - Journal of …, 2021 - Taylor & Francis
Abstract The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which was
first reported in Wuhan province of China, has become a deadly pandemic causing …
first reported in Wuhan province of China, has become a deadly pandemic causing …
In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2
RR Deshpande, AP Tiwari, N Nyayanit… - European journal of …, 2020 - Elsevier
SARS-CoV-2 has devastated the world with its rapid spread and fatality. The researchers
across the globe are struggling hard to search a drug to treat this infection. Understanding …
across the globe are struggling hard to search a drug to treat this infection. Understanding …
Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2
Abstract Angiotensin converting enzyme 2 (ACE2)(EC: 3.4. 17.23) is a transmembrane
protein which is considered as a receptor for spike protein binding of novel coronavirus …
protein which is considered as a receptor for spike protein binding of novel coronavirus …